Characteristic | Frequency (%) |
---|---|
D onor-recipient sex match-no. (%) | Â |
   Male-male | 85(41.3) |
   Male-female | 54(26.2) |
   Female-male | 36(17.5) |
   Female-female | 31(15) |
A ge Mean(SD) | 22.5(8.73) |
A ge(years), Median(range) | 20(2–51) |
D onor age, Median(range) | 21(2–55) |
A ge group – no. (%) |  |
   < 15 yr | 37(18) |
   16–20 yr | 72(35) |
   21–30 yr | 64(31.1) |
   31–40 yr | 22(10.7) |
   > 40 yr | 11(5.3) |
O utcomes-no. (%) | Â |
   Death | 76(39.9) |
   Relapse | 59(28.6) |
   aGVHD | 136(77.7) |
   cGVHD | 34(24.1) |
   Platelet recovery | 141(75.0) |
   Neutrophil recovery | 167(85.6) |
T ime of aGVHD-day | Â |
   Mean(SD) | 13.3(16.5) |
   Median | 9 |
   Range | 3–90 |
T ime of cGVHD-day | Â |
   Mean(SD) | 160.26(73.4) |
   Median | 140 |
   Range | 91–327 |
T ime of relapse-day | Â |
   Mean(SD) | 580(555) |
   Median | 412 |
   Range | 10–2661 |
T ime of platelet recovery-day | Â |
   Mean(SD) | 20.8(19.2) |
   Median | 17 |
   Range | 1–165 |
T ime of neutrophil recovery-day | Â |
   Mean(SD) | 13.46(12.8) |
   Median | 11 |
   Range | 1–160 |
F ollow up-month | Â |
   Median | 16 |
   range | 3–89 |